Neuroimaging Through the Course of Alzheimer's Disease

被引:17
|
作者
Smith, Charles D. [1 ]
机构
[1] Univ Kentucky, Rush Alzheimers Dis Ctr, Sanders Brown Ctr Aging,Chandler Med Ctr, Dept Neurol,Magnet Resonance Imaging & Spect Ctr, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; computed tomography; diffusion tensor imaging; FDG; functional imaging; human; magnetic resonance imaging; mild cognitive impairment; morphometry; PIB; positron emission tomography; prediction; review; MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; POSITRON-EMISSION-TOMOGRAPHY; WHITE-MATTER DAMAGE; MEDIAL TEMPORAL ATROPHY; DIFFUSION-TENSOR; BRAIN ATROPHY; DEFAULT-MODE; HIPPOCAMPAL ATROPHY; AMYLOID DEPOSITION;
D O I
10.3233/JAD-2010-1217
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This review uses an image-indexed framework for the full course of Alzheimer's disease (AD) to provide a perspective on recent neuroimaging findings in the literature. Modalities considered include morphometric, diffusion tensor, and functional magnetic resonance imaging, and resting/functional metabolic and amyloid-label positron emission tomography. The major focus is on the AD pre-states (normal but high AD risk and mild cognitive impairment), and transition from mild cognitive impairment to mild AD. Imaging results relevant to the conduct of future prevention and early intervention trials are emphasized.
引用
收藏
页码:273 / 290
页数:18
相关论文
共 50 条
  • [1] Transfer Learning for Alzheimer's Disease through Neuroimaging Biomarkers: A Systematic Review
    Agarwal, Deevyankar
    Marques, Goncalo
    de la Torre-Diez, Isabel
    Franco Martin, Manuel A.
    Garcia Zapirain, Begona
    Martin Rodriguez, Francisco
    SENSORS, 2021, 21 (21)
  • [2] Neuroimaging Biomarkers for Alzheimer's Disease
    Marquez, Freddie
    Yassa, Michael A.
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [3] Molecular Neuroimaging in Alzheimer's Disease
    Matsuda, Hiroshi
    Imabayashi, Etsuko
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2012, 22 (01) : 57 - +
  • [4] Neuroimaging of Mouse Models of Alzheimer's Disease
    Jullienne, Amandine
    Trinh, Michelle V.
    Obenaus, Andre
    BIOMEDICINES, 2022, 10 (02)
  • [5] The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques
    Li, Tie-Qiang
    Wahlund, Lars-Olof
    ACTA RADIOLOGICA, 2011, 52 (02) : 211 - 222
  • [6] Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative
    Ellis, Kathryn A.
    Rowe, Christopher C.
    Villemagne, Victor L.
    Martins, Ralph N.
    Masters, Colin L.
    Salvado, Olivier
    Szoeke, Cassandra
    Ames, David
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 291 - 296
  • [7] Staging Alzheimer's disease progression with multimodality neuroimaging
    Ewers, Michael
    Frisoni, Giovanni B.
    Teipel, Stefan J.
    Grinberg, Lea T.
    Amaro, Edson, Jr.
    Heinsen, Helmut
    Thompson, Paul M.
    Hampel, Harald
    PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 535 - 546
  • [8] Applications of neuroimaging to disease-modification trials in Alzheimer's disease
    Fleisher, Adam S.
    Donohue, Michael
    Chen, Kewei
    Brewer, James B.
    Aisen, Paul S.
    BEHAVIOURAL NEUROLOGY, 2009, 21 (1-2) : 129 - 136
  • [9] Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review
    Aramadaka, Saikumar
    Mannam, Raam
    Narayanan, Rajagopal Sankara
    Bansal, Arpit
    Yanamaladoddi, Vishnu R.
    Sarvepalli, Sai Suseel
    Vemula, Shree Laya
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [10] Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease
    Zimmer, Jennifer A.
    Shcherbinin, Sergey
    Devous, Michael D., Sr.
    Bragg, Sonja M.
    Selzler, Katherine J.
    Wessels, Alette M.
    Shering, Craig
    Mullen, Jamie
    Landry, John
    Andersen, Scott W.
    Downing, AnnCatherine M.
    Fleisher, Adam S.
    Svaldi, Diana Otero
    Sims, John R.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2021, 7 (01)